These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 17395656)
1. Quality of life assessment in a recent haemoglobin trial in CKD (CHOIR). Kutner N Nephrol Dial Transplant; 2007 Jul; 22(7):2099. PubMed ID: 17395656 [No Abstract] [Full Text] [Related]
2. Understanding recent haemoglobin trials in CKD: methods and lesson learned from CREATE and CHOIR. Levin A Nephrol Dial Transplant; 2007 Feb; 22(2):309-12. PubMed ID: 17234670 [No Abstract] [Full Text] [Related]
3. Target hemoglobin level for EPO therapy in CKD. Parfrey PS Am J Kidney Dis; 2006 Jan; 47(1):171-3. PubMed ID: 16377399 [No Abstract] [Full Text] [Related]
4. Hemoglobin normalization trials in chronic kidney disease: what should we learn about quality of life as an end point? Covic A; Seica A; Gusbeth-Tatomir P; Goldsmith D J Nephrol; 2008; 21(4):478-84. PubMed ID: 18651536 [TBL] [Abstract][Full Text] [Related]
5. Managing anemia. What do we do now? Views from Canada. Mendelssohn DC; Muirhead N; Manns BJ Nephrol News Issues; 2007 Jun; 21(7):55-7. PubMed ID: 17623988 [No Abstract] [Full Text] [Related]
6. Anaemia of CKD--the CHOIR study revisited. Singh AK; Szczech L; Tang KL; Barnhart H; Sapp S; Wolfson M; Reddan D Nephrol Dial Transplant; 2007 Jul; 22(7):1806-10. PubMed ID: 17420166 [No Abstract] [Full Text] [Related]
8. Treating anemia with erythropoiesis-stimulating agents: effects on quality of life. Moossavi S; Freedman BI Arch Intern Med; 2009 Jun; 169(12):1100-1. PubMed ID: 19546408 [No Abstract] [Full Text] [Related]
9. The target hemoglobin in patients with chronic kidney disease. Singh AK Nephrol News Issues; 2006 Dec; 20(13):29-30. PubMed ID: 17168056 [No Abstract] [Full Text] [Related]
10. The optimal hemoglobin in dialysis patients- a critical review. Singh AK; Fishbane S Semin Dial; 2008; 21(1):1-6. PubMed ID: 18251947 [TBL] [Abstract][Full Text] [Related]
11. Anemia and response to epoetin alfa: the cause of anemia matters! Dharmarajan TS J Am Geriatr Soc; 2008 Aug; 56(8):1574-5. PubMed ID: 18808607 [No Abstract] [Full Text] [Related]
12. ESA therapy for anemia management: a call for civil discourse. McAllister CJ Nephrol News Issues; 2007 Jun; 21(7):49-50. PubMed ID: 17623986 [No Abstract] [Full Text] [Related]
15. [Regarding the optimal hemoglobin target range in renal anemia]. Maurin N Med Klin (Munich); 2008 Sep; 103(9):633-7. PubMed ID: 18813886 [TBL] [Abstract][Full Text] [Related]
16. Creating a better environment to treat anemia in patients with CKD. Sinnen MT Nephrol Nurs J; 2007; 34(6):645-9. PubMed ID: 18203573 [No Abstract] [Full Text] [Related]
17. The controversy surrounding hemoglobin and erythropoiesis-stimulating agents: what should we do now? Singh AK Am J Kidney Dis; 2008 Dec; 52(6 Suppl):S5-13. PubMed ID: 19010260 [TBL] [Abstract][Full Text] [Related]
18. Hemoglobin variability in dialysis patients. Brimble KS; Clase CM J Am Soc Nephrol; 2007 Aug; 18(8):2218-20. PubMed ID: 17627931 [No Abstract] [Full Text] [Related]
19. Triumph and tragedy: anemia management in chronic kidney disease. Novak JE; Szczech LA Curr Opin Nephrol Hypertens; 2008 Nov; 17(6):580-8. PubMed ID: 18941350 [TBL] [Abstract][Full Text] [Related]